Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2026-03-24 @ 4:53 PM
Study NCT ID:
NCT07247656
Status:
COMPLETED
Last Update Posted:
2025-11-25
First Post:
2025-09-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Efficacy and Safety of Empagliflozin - Linagliptin and Empagliflozin- Metformin Therapy in Reduction of Body Weight in Type 2 Diabetic Patients .
Sponsor:
Bahria University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-01
Completion Date Type:
ACTUAL
First Submit Date:
2025-09-17
First Submit QC Date:
None
Study First Post Date:
2025-11-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-22
Last Update Post Date:
2025-11-25
Last Update Post Date Type:
ESTIMATED